Triplet Induction + 1 or 2-Drug Maintenance
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance
Near Add Your Location
Sorting 370 by
- Accepting patients
University of Arkansas for Medical Sciences (UAMS)
Little Rock, AR
- Accepting patients
- Accepting patients
Smilow Cancer Hospital at Yale New Haven
New Haven, CT
- Accepting patients
Herbert Irving Comprehensive Cancer Center (Columbia University)
Columbia University Medical Center
New York, NY
- Accepting patients
- Accepting patients
- Accepting patients
- Accepting patients
Mayo Clinic (Jacksonville)
Jacksonville, FL
- Accepting patients
University of Oklahoma Health Sciences Center
Oklahoma City, OK
- Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.